Skip to main content
SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD logo

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD — Investor Relations & Filings

Ticker · 688389 ISIN · CNE100005WZ5 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2026-04-15 Investor Presentation
Country CN China
Listing Shanghai Stock Exchange 688389

About SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD

https://en.lifotronic.com/

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD. specializes in the research, development, and manufacturing of medical equipment for therapeutic and diagnostic applications. The company’s therapeutic portfolio includes negative pressure wound therapy (NPWT) systems, high-frequency chest wall oscillation devices for airway clearance, and various physical therapy and rehabilitation solutions. In the field of in-vitro diagnostics, it offers high-performance liquid chromatography (HPLC) hemoglobin analyzers for diabetes management and chemiluminescence immunoassay (CLIA) platforms. Lifotronic integrates advanced engineering with clinical requirements to provide solutions for wound care, respiratory health, and laboratory testing. The company serves a global market, focusing on technological innovation and the delivery of precise, reliable medical instruments designed to improve patient outcomes across diverse clinical settings.

Recent filings

Filing Released Lang Actions
深圳普门科技股份有限公司关于召开2025年年度暨2026年第一季度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling of an earnings explanation meeting (业绩说明会) for the 2025 annual results and 2026 first quarter results. It provides details about the meeting time, location, participation method, and contact information. It explicitly states that the company will disclose the 2025 annual report and 2026 first quarter report on April 23, 2026, and then hold the earnings explanation meeting on April 24, 2026. The document does not contain actual financial data or detailed financial statements but serves as a notice for the upcoming earnings call and related reports. According to the classification rules, such announcements about meetings to discuss earnings results are classified as Call Transcript (CT) if they contain the transcript, or if only announcing the meeting, they are closer to Investor Presentation (IP) or Regulatory Filings (RNS). However, since this document is announcing the earnings explanation meeting (a form of investor presentation focused on financial results) and not the transcript or the report itself, the best fit is Investor Presentation (IP). The document is not the actual earnings release (ER) or interim report (IR) because it lacks financial data. It is also not a Report Publication Announcement (RPA) because it does not merely announce the report but announces the meeting to discuss the results. Therefore, the classification is Investor Presentation (IP) with high confidence.
2026-04-15 Chinese
深圳普门科技股份有限公司关于2022年股票期权激励计划2026年第一季度自主行权结果的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shenzhen Pumen Technology Co., Ltd. regarding the stock option incentive plan's exercise results for the first quarter of 2026. It details the number of stock options exercisable, exercised, and the related corporate governance and board approvals. The document is a formal disclosure of stock option exercise results and related corporate decisions, not a financial report or earnings release. It is not a full annual or interim report, nor a call transcript or investor presentation. It is a regulatory announcement about stock option exercise results, which fits best under the category of Regulatory Filings (RNS) as it does not fit other more specific categories and is a formal regulatory disclosure.
2026-04-01 Chinese
深圳普门科技股份有限公司关于2022年股票期权激励计划限制行权期间的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (645 characters) from Shenzhen Pumen Technology Co., Ltd. regarding the restriction period for exercising stock options under the 2022 stock option incentive plan. It includes specific dates for the restriction period and mentions compliance with relevant regulations. There is no detailed financial data, no full report, and no mention of an attached or published report. The content is about a capital-related update concerning stock option exercise restrictions, which fits best under Capital/Financing Update (CAP).
2026-04-01 Chinese
深圳普门科技股份有限公司关于2026年股票期权激励计划授予登记完成的公告
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from Shenzhen Pumen Technology Co., Ltd. regarding the completion of the registration of stock option grants under the 2026 stock option incentive plan. It details the number of options granted, the recipients, the pricing, the decision-making process, and the accounting impact of the stock option plan. The document is a formal disclosure about a capital-related event, specifically the issuance of stock options to employees and management, which affects the company's capital structure. It is not a full financial report, audit report, or earnings release, nor is it a meeting presentation or voting result. It is an announcement about a capital change event related to share issuance under an employee stock option plan. Therefore, the most appropriate classification is "Share Issue/Capital Change (SHA)". The document length is 4614 characters, which is sufficient to contain substantive details about the capital change event rather than just a brief notice or a report publication announcement. Confidence is high given the detailed nature of the disclosure and the clear focus on stock option grant registration.
2026-03-27 Chinese
深圳普门科技股份有限公司关于自愿披露取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure announcement by Shenzhen Pumen Technology Co., Ltd. regarding the receipt of a medical device registration certificate issued by the Guangdong Provincial Drug Administration. It details the product name, registration classification, certificate number, validity period, and product application scope. The document discusses the impact of this registration on the company's product offerings and market competitiveness, and includes a risk warning about the uncertainty of future sales impact. The document is short (974 characters) and serves as an official announcement of a regulatory approval rather than a financial report or detailed operational update. It does not contain financial data, management changes, or voting results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-03-24 Chinese
深圳普门科技股份有限公司关于自愿披露取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement by Shenzhen Pumen Technology Co., Ltd. regarding the voluntary disclosure of obtaining a medical device registration certificate issued by the Guangdong Provincial Drug Administration. It details the product name, registration classification, certificate number, validity period, and intended use. The document discusses the impact of this registration on the company and includes a risk warning about the uncertainty of the product's future sales impact. The document is short (957 characters) and serves as a regulatory announcement about a product certification rather than a financial report or detailed management discussion. It does not contain financial data, earnings, or management changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-03-09 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.